Ikarian Capital, LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Ikarian Capital, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 12, 2022	BUY	$11.23 - $19.59 $2.81 Million - $4.9 Million	250,000 Added 250.0%	350,000 $4.83 Million
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $1.93 Million - $3.78 Million	100,000 New	100,000 $2.31 Million
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $5.86 Million - $8.02 Million	-150,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $4.67 Million - $9.2 Million	100,000 Added 200.0%	150,000 $7.19 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $720,415 - $1.77 Million	-14,900 Reduced 22.96%	50,000 $3.15 Million

Q4 2019 Jan 31, 2020	BUY	$57.36 - $124.1 $3.72 Million - $8.05 Million	64,900 New	64,900 $8.04 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.